Benchmarking DEWÄKSS on a predefined benchmark test [29]. by Andreas Tjärnberg (3438332)

Assessment of exoprotein concentration in a 50-mL culture of MH96. by Marion Schoof (11999106)

<i>In vitro</i> treatment with the broad spectrum caspase inhibitor Q-VD-OPh reduces the number of active caspase-3-positive cells in parallel with a decrease in the entry of micro... by María Martín-Estebané (623506)

Change in activity participation compared to the baseline for normal workdays. by Sebastian A. Müller (10688740)

Stromal cells from various non-lymphoid organs decrease antigen-specific T cell proliferation. by Stefanie Siegert (196565)

Non-hematopoietic IFN-γ response results in decrease expression of hepatic CXCR3 on T lymphocytes. by Tamir Diamond (12822347)

C2GnT1 gene knockdown decreases C2-O-sLe^X glycoproteins and C2GnT1 activity. by Catherine A. St. Hill (357388)

“…Note the absence of a detected C2GnT1 protein 50 kDa band. (D) We observed a 30–40% decrease in reactivity with CHO-131 mAb by flow cytometry for LS174T and HepG2 cells that contained C2GnT1 shRNA. …”

Alpha-smooth muscle actin (ASMA) is decreased while vimentin is increased in non-dilated bicuspid aortic valve (BAV)-associated aortas. by Brittany Balint (6829967)

Treatment with mitochondrial shuttle inhibitors, GKA50, Ranolazine and glucose results in significant decreases in superoxide concentration as detected by coelenterazine chemilumin... by Laura L. Bronsart (844933)

Differential gene expression assay EC₅₀ values in Huh-7 cells and PHH. by Xuan G. Luong (9761423)

GR expression is decreased in the SCLC cells compared to non-SCLC cells and bronchial epithelial cells. by Paul Kay (342717)

T1DM decreases cerebral vascular perfusion in the cerebral parenchyma compared to non-DM rats. by Tao Yan (429415)

Apoptosis in lactotropes but not in non-lactotrope cells varies during the estrous cycle and decreases in PRLRKO mice. by Jimena Ferraris (314722)

The incidence rate of distant CRC is decreasing much more slowly than non-distant disease. by Gaius Julian Augustus (5509046)

NaHS decreased TGF-β1-stimulated overexpression of non-phosphorylated β-catenin. by Lin Guo (113004)

Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Protocol measures. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Cry variables. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

“…Phosphorylation can reduce toxicity and improve the stability of AMPs. Based on these, we designed a series of peptides and their corresponding phosphorylated forms. …”

Number of inferred basal bacterial imports decreases with added genomes. by Erin A. Becker (488025)